2[1]Kaai EM, Sasano H, Suzuki T, et al.Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.Mol Hum Reprod,2000,6:443～447.
3[2]Pirwany IR, Yates RW, Cameron IT, et al.Effects of the insulin sensitizing drag metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.Hum Reprod, 1999,14:2963～2968.
4[3]Tropeano G,Liberale I, Vuolo IP, et al.Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome.J Endocrinol Invest,1997,20(4):220～224.
5[4]Young RH.Dusting off old books: comments on classic gynecologic pathology books of yesteryear.Int J Gynecol Pathol, 2000, 19:6～84.
6[5]Ferraretti AP, Gianaroli L, Magli MC, et al.Transvagifial ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.Fertil Steril, 2001,76:812～816.
7Lobo RA.The perimenopause[].Clinical Obstetrics and Gynecology.1998
8Mac mahon B.Risk factors for endometrial cancer[].Gynecologic Oncology.1974
9Wallace RB,Sherman BM,Bean JA,et al.Probability of menopause with increasing duration of amenorrhea in middle- aged women[].American Journal of Obstetrics and Gynecology.1979
10Hawwa ZM,Nahhas WA,Copenhaven EH.Postmenopausal bleeding[].Lahey Clinic Foundation Bulletin.1970
